Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Prieto

Showing results (301-310 of 753) with videos related to

Pageof 76
Sort By:
Chemotherapy|September 1, 1996
Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitroF Fuentes, M M Martín, J Izquierdo, et al.
Journal of Hepatology|November 1, 1993
Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferonJ Camps, N García, J I Riezu-Boj, et al.
The Canadian Journal of Cardiology|April 29, 2000
Factors predictive of oxygen consumption during the immediate postoperative period in open heart surgeryR Cartier, J Prieto, Y Leclerc, et al.
The Journal of Hand Surgery|August 14, 1999
Upper extremity infections in patients with diabetes mellitusM H Gonzalez, S Bochar, J Novotny, et al.
Journal of Chemotherapy (Florence, Italy)|January 12, 2001
In vitro activity of clarithromycin against penicillin-susceptible and penicillin-resistant strains of Streptococcus pneumoniae in a pharmacodynamic simulation modelF Fuentes, D Sevillano, I P Balcabao, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1996
Postantifungal effect and effects of low concentrations of amphotericin B and fluconazole on previously treated Candida albicansF Mínguez, M T García, J E Lima, et al.
Neurologia (Barcelona, Spain)|February 1, 2014
Transcultural adaptation and validation of the Spanish version of EUROQUESTD Marhuenda, M J Prieto, A Cardona, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coliF Fuentes, J Izquierdo, M M Martín, et al.
Chemotherapy|January 1, 1995
Enhancement of the susceptibility of Staphylococcus aureus to phagocytosis after treatment with fosfomycin compared with other antimicrobial agentsP Pérez Fernández, I Herrera, P Martínez, et al.
Chemosphere|August 28, 2016
The ability of electrochemical oxidation with a BDD anode to inactivate Gram-negative and Gram-positive bacteria in low conductivity sulfate mediumCarmina Bruguera-Casamada, Ignasi Sirés, María J Prieto, et al.
Pageof 76

Showing results (301-310 of 753) with videos related to

Sort By:
Pageof 76
Chemotherapy|September 1, 1996
Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitroF Fuentes, M M Martín, J Izquierdo, et al.
Journal of Hepatology|November 1, 1993
Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferonJ Camps, N García, J I Riezu-Boj, et al.
The Canadian Journal of Cardiology|April 29, 2000
Factors predictive of oxygen consumption during the immediate postoperative period in open heart surgeryR Cartier, J Prieto, Y Leclerc, et al.
The Journal of Hand Surgery|August 14, 1999
Upper extremity infections in patients with diabetes mellitusM H Gonzalez, S Bochar, J Novotny, et al.
Journal of Chemotherapy (Florence, Italy)|January 12, 2001
In vitro activity of clarithromycin against penicillin-susceptible and penicillin-resistant strains of Streptococcus pneumoniae in a pharmacodynamic simulation modelF Fuentes, D Sevillano, I P Balcabao, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1996
Postantifungal effect and effects of low concentrations of amphotericin B and fluconazole on previously treated Candida albicansF Mínguez, M T García, J E Lima, et al.
Neurologia (Barcelona, Spain)|February 1, 2014
Transcultural adaptation and validation of the Spanish version of EUROQUESTD Marhuenda, M J Prieto, A Cardona, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coliF Fuentes, J Izquierdo, M M Martín, et al.
Chemotherapy|January 1, 1995
Enhancement of the susceptibility of Staphylococcus aureus to phagocytosis after treatment with fosfomycin compared with other antimicrobial agentsP Pérez Fernández, I Herrera, P Martínez, et al.
Chemosphere|August 28, 2016
The ability of electrochemical oxidation with a BDD anode to inactivate Gram-negative and Gram-positive bacteria in low conductivity sulfate mediumCarmina Bruguera-Casamada, Ignasi Sirés, María J Prieto, et al.
Pageof 76